Adaptive Biotechnologies Corporation
- ADPT
- NASDAQ
- Biotechnology
- Immune Repertoire Diagnostics
- MRD Testing
$24.02
Today −6.10%Quote Oct 16, 2026, 08:00 PM UTC
−15.87%over the last month
Max drawdown −19.5%From 1-month high −19.5%3 months +9.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$3.83B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$31.58
+31.5% from here
Floor
$21.83
9.1% below price
Where the price sits
17 analysts
Analyst range, low to high
$27.00$35.00
- Price $24.02
- Resistance $24.16
- Consensus $31.58
The price is right under resistance. Analysts' average target sits about 31% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ADPTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
624
Founded
2009